HALO - Halozyme Therapeutics Q2 2020 Earnings Preview

August, 09 2020 05:35 PM Halozyme Therapeutics Inc.

Halozyme Therapeutics (NASDAQ:HALO) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close.
The consensus EPS Estimate is $0.24 vs. -$0.10 in 2Q19 and the consensus Revenue Estimate is $65.81M (+68.1% Y/Y).
Over the last 2 years, HALO has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
Over the last 3 months, EPS estimates have seen 7 upward revisions and 2 downward. Revenue estimates have seen 7 upward revisions and 0 downward.
More news on: Halozyme Therapeutics, Inc., Earnings news and commentary, , Healthcare stocks news,